» Authors » Alessandra Bortoluzzi

Alessandra Bortoluzzi

Explore the profile of Alessandra Bortoluzzi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 106
Citations 1272
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Elia A, Zucchi D, Silvagni E, Oliva M, Cascarano G, Cardelli C, et al.
Clin Exp Rheumatol . 2025 Mar; 43(3):397-406. PMID: 40072872
This review highlights key advancements in systemic lupus erythematosus (SLE) research during 2024, covering pathogenesis, novel therapies, biomarkers, and clinical outcomes. Notable findings include new insights into immune dysregulation, promising...
2.
Sciascia S, Bonelli G, Calatroni M, LImperio V, Fenoglio R, Argolini L, et al.
Minerva Urol Nephrol . 2025 Mar; PMID: 40052259
No abstract available.
3.
Bonelli G, Sciascia S, Calatroni M, LImperio V, Fenoglio R, Argolini L, et al.
J Nephrol . 2025 Jan; PMID: 39883361
Background: In an Italian cohort of lupus podocytopathy patients, we aimed to characterize the presenting features, therapy, and outcomes, and explore differences between relapsing and non-relapsing patients. Methods: We identified...
4.
Katechis S, Pitsigavdaki S, Nikoloudaki M, Silvagni E, Repa A, Marangoni A, et al.
RMD Open . 2025 Jan; 11(1). PMID: 39762120
Objective: Glucocorticoid (GC) tapering and withdrawal to reduce damage represents a key aspect of the European Alliance of Associations for Rheumatology (EULAR) SLE recommendations. However, optimal strategies for relapse-free GC...
5.
Sloan M, Bourgeois J, Leschziner G, Pollak T, Pitkanen M, Harwood R, et al.
EClinicalMedicine . 2024 Oct; 73:102634. PMID: 39429812
Background: Neuropsychiatric symptoms in SLE and other systemic autoimmune rheumatic diseases (SARDs) are challenging to diagnose, attribute and manage. We investigated the timings of onset of a broad range of...
6.
Andreoli L, Gerardi M, Gerosa M, Rozza D, Crisafulli F, Erra R, et al.
RMD Open . 2024 Apr; 10(2). PMID: 38663885
Objectives: To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) in the Italian prospective cohort study P-RHEUM.it. Methods: Pregnant women with different ARD were enrolled for up to...
7.
Schiliro D, Silvagni E, Ciribe B, Fattorini F, Maccarrone V, Elefante E, et al.
Clin Exp Rheumatol . 2024 Mar; 42(3):583-592. PMID: 38545801
Systemic lupus erythematosus (SLE) is classically regarded as the landmark of systemic autoimmune diseases, characterised by protean, multi-systemic manifestations and a highly variable clinical course.Over the last years, both clinical...
8.
Sloan M, Pollak T, Massou E, Leschziner G, Andreoli L, Harwood R, et al.
Rheumatology (Oxford) . 2024 Mar; 64(3):1179-1192. PMID: 38518094
Objective: Attribution of neuropsychiatric symptoms in systemic lupus erythematosus (SLE) relies heavily on clinician assessment. Limited clinic time, variable knowledge and symptom under-reporting contribute to discordance between clinician assessments and...
9.
Bortoluzzi A, Fanouriakis A, Silvagni E, Appenzeller S, Carli L, Carrara G, et al.
Rheumatology (Oxford) . 2024 Feb; 63(10):2711-2720. PMID: 38402539
Objectives: The management of neuropsychiatric systemic lupus erythematosus (NPSLE) poses considerable challenges due to limited clinical trials. Therapeutic decisions are customized based on suspected pathogenic mechanisms and symptoms severity. This...
10.
Castellazzi M, Candeloro R, Pugliatti M, Govoni M, Silvagni E, Bortoluzzi A
Diagnostics (Basel) . 2024 Feb; 14(3). PMID: 38337758
The analysis of cerebrospinal fluid (CSF) remains a valuable diagnostic tool in the evaluation of inflammatory and infectious conditions involving the brain, spinal cord, and meninges. Since many rheumatic inflammatory...